Rod Chalk

Rod Chalk

Auto-generated profile, based on publicly available information

Rod Chalk

Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
GNGabriela Dias Noske
Gabriela Dias Noske
YSYun Song
Yun Song
RFRafaela Fernandes
Rafaela Fernandes
RCRod Chalk
Rod Chalk
HEHaitem Elmassoudi
Haitem Elmassoudi
AGAndre Godoy
Andre Godoy
The main protease from SARS-CoV-2 (Mpro) is responsible for cleavage of the viral polyprotein. Mpro self-processing is called maturation, and it is crucial for enzyme dimerization and activity. Here we use C145S Mpro to study the structure and dynamics of N-terminal cleavage in solution. Native mass spectroscopy analysis shows that mixed oligomeric states are composed of cleaved and uncleaved particles, indicating that N-terminal processing is not critical for dimerization. A 3.5 Å cryo-EM structure provides details of Mpro N-terminal cleavage outside the constrains of crystal environment. We show that different classes of inhibitors shift the balance between oligomeric states. While non-covalent inhibitor MAT-POS-e194df51-1 prevents dimerization, the covalent inhibitor nirmatrelvir induces the conversion of monomers into dimers, even with intact N-termini. Our data indicates that the Mpro dimerization is triggered by induced fit due to covalent linkage during substrate processing rather than the N-terminal processing.

1 December 2001 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
FLFionnuala T Lundy
Fionnuala T Lundy
RCRod Chalk
Rod Chalk
PLPhilip-John Lamey
Philip-John Lamey
CSChristopher Shaw
Christopher Shaw
GLGerard J. Linden
Gerard J. Linden

13 May 2020 in bioRxiv
Verified
Preprint
Open access
LNLaiyin Nie
Laiyin Nie
ESEric Spear
Eric Spear
TBTimothy D. Babatz
Timothy D. Babatz
AQAndrew Quigley
Andrew Quigley
Yin Yao DongYin Yao Dong
Yin Yao Dong
ECElisabeth P. Carpenter
Elisabeth P. Carpenter
Human ZMPSTE24, an integral membrane zinc metalloprotease, is required for conversion of prelamin A to mature lamin A, a component of the nuclear lamina and failure of this processing causes premature ageing disorders. ZMPSTE24 has also been implicated in both type 2 diabetes mellitus and in viral-host response mechanisms, but to date its only confirmed substrate is the precursor for lamin A. Prelamin A is thought to undergo four C-terminal post-translational modifications in the following order: farnesylation, SIM tripeptide cleavage, carboxymethylation and upstream “SY^LL” cleavage. Here we present evidence that the sequence of events does not follow the accepted dogma. We assessed cleavage of long human prelamin A sequence peptides by purified human ZMPSTE24 combined with FRET and mass spectrometry to detect products. Surprisingly, we found that the “SY^LL” cleavage occurs before and independent of the C-terminal CSIM modifications. We also found that ZMPSTE24 does not perform the predicted C^SIM tripeptide cleavage, but rather it removes an IM dipeptide. ZMPSTE24 can perform a tripeptide cleavage with a canonical CaaX box (C: cysteine; a: aliphatic; X: any residue), but the C-terminus of prelamin A is not a true CaaX sequence. Regardless of the C-terminal modifications of prelamin A, ZMPSTE24 can perform upstream SY^LL cleavage, thus removing the unwanted farnesylated C-terminus. Therefore, it is failure of SY^LL cleavage, not the C-terminal processing that is the likely cause of progeroid disorders.

3 August 2021 in Communications Biology
Verified
Journal Article
Open access
PDF file
RCRod Chalk
Rod Chalk
WGWilliam E. P. Greenland
William E. P. Greenland
TMTiago Moreira
Tiago Moreira
JCJesse Coker
Jesse Coker
SMShubhashish M. M. Mukhopadhyay
Shubhashish M. M. Mukhopadhyay
NBNicola A. Burgess-Brown
Nicola A. Burgess-Brown
We describe an analytical method for the identification, mapping and relative quantitation of glycopeptides from SARS-CoV-2 Spike protein. The method may be executed using a LC-TOF mass spectrometer, requires no specialized knowledge of glycan analysis and exploits the differential resolving power of reverse phase HPLC. While this separation technique resolves peptides with high efficiency, glycans are resolved poorly, if at all. Consequently, glycopeptides consisting of the same peptide bearing different glycan structures will all possess very similar retention times and co-elute. Rather than a disadvantage, we show that shared retention time can be used to map multiple glycan species to the same peptide and location. In combination with MSMS and pseudo MS3, we have constructed a detailed mass-retention time database for Spike glycopeptides. This database allows any accurate mass LC-MS laboratory to reliably identify and quantify Spike glycopeptides from a single overnight elastase digest in less than 90 minutes.

2 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
TPTomas C. Pascoa
Tomas C. Pascoa
APAshley C.W. Pike
Ashley C.W. Pike
CTChristofer S Tautermann
Christofer S Tautermann
GCGamma Chi
Gamma Chi
MTMichael Traub
Michael Traub
DSDavid B. Sauer
David B. Sauer
Ceramides are bioactive sphingolipids that play pivotal roles in regulating cellular metabolism. Ceramides and dihydroceramides are synthesized by a family of six ceramide synthase enzymes (CerS), each with distinct specificity for the acyl-CoA substrate. Importantly, the acyl chain length plays a key role in determining the physiological function of ceramides, as well as their role in metabolic disease. Ceramide with an acyl chain length of 16 carbons (C16 ceramide) has been implicated in obesity, insulin resistance and liver disease, and the C16 ceramide-synthesizing CerS6 is regarded as an attractive drug target for obesity-associated disease. Despite their importance, the molecular mechanism underlying ceramide synthesis by CerS enzymes remains poorly understood. Here, we report cryo-electron microscopy structures of human CerS6, capturing covalent intermediate and product-bound states. These structures, together with biochemical characterization using intact protein and small molecule mass spectrometry, reveal that CerS catalysis proceeds via a ping-pong reaction mechanism involving a covalent acyl-enzyme intermediate. Notably, the product-bound structure was obtained upon reaction with the mycotoxin fumonisin B 1 , providing new insights into its inhibition of CerS. These results provide a framework for understanding the mechanisms of CerS function, selectivity, and inhibition, and open new directions for future drug discovery targeting the ceramide and sphingolipid pathways.

16 September 2025 in bioRxiv
Verified
Preprint
Open access
CWCarys Williams
Carys Williams
LNLaura M. Nocka
Laura M. Nocka
GHGeorge Hedger
George Hedger
PPPragya Parashara
Pragya Parashara
EPEls Pardon
Els Pardon
RRRajat Rohatgi
Rajat Rohatgi
Summary: Receptor-type E3 ubiquitin ligases are membrane-spanning assemblies that enable extracellular signals to directly control ubiquitylation in the cytoplasm. Despite playing widespread roles in tissue patterning and homeostasis, metabolism, and immunity, their structures and mechanisms remain poorly understood. Using cryo-electron microscopy, integrated with biophysical and functional studies, we visualized an E3 complex composed of two transmembrane proteins, MEGF8 and MOSMO, and the intracellular RING-family protein MGRN1. This MEGF8-MOSMO-MGRN1 (MMM) complex regulates left-right patterning of the body axis and the development of multiple organs, partly by attenuating signaling through the Hedgehog pathway. We find that the MMM complex functions like a fishing pole: a long, flexible helix attached to a membrane platform suspends an activated and precisely oriented RING domain—like a fishhook—to ubiquitylate the cytoplasmic surfaces of target receptors. Our structure explains how mutations in MEGF8 cause multi-organ birth defects in humans and defines a paradigm for receptor regulation by ubiquitylation.